HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
LFST
LifeStance Health Group, Inc.
LFST's fundamentals are strong: revenue grew 23% and its operating margin rose 6 points to 6.2%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
LFST Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
LFST's revenue, profitability, cash flow and balance sheet are all currently healthy.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
LFST PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 54x | $14.15 | — |
| Current | 74x | $14.15 | — |
| Cheap | 95x | $17.99 | +27% |
| Fair | 128x | $24.39 | +72% |
| Expensive | 319x | $60.61 | +328% |
Historical ranges are pointers, not guarantees.
LFST's PE is 74x, but its earnings don't support one, so it isn't a reliable read right now.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
LFST Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
LFST has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
LFST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.26 | +39% |
| Q3 2026 | $0.19 | +$0.21 |
| Q2 2026 | $0.13 | +$0.17 |
| Q1 2026 | $0.06 | +$0.15 |
| Q4 2025 | $0.02 | +$0.17 |
LFST has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over LFST on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
LFST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $455.9M | +25% |
| Q2 2026 | $435.4M | +26% |
| Q1 2026 | $403.5M | +21% |
| Q4 2025 | $382.2M | +17% |
| Q3 2025 | $363.8M | +16% |
| Q2 2025 | $345.3M | +11% |
| Q1 2025 | $333M | +11% |
| Q4 2024 | $325.5M | +16% |
LFST's revenue has grown year over year every quarter since early 2021: $456M last quarter, up 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.3% | +5.2 points |
| Q2 2026 | 7% | +7.9 points |
| Q1 2026 | 5.5% | +5 points |
| Q4 2025 | 4.7% | +4.4 points |
| Q3 2025 | 2% | +2 points |
| Q2 2025 | -0.8% | +4.3 points |
| Q1 2025 | 0.5% | +6.1 points |
| Q4 2024 | 0.3% | +12 points |
LFST has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over LFST on cash flow, with more consistent year-over-year improvement.
LFST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $22.4M | +32% |
| Q2 2026 | $87.9M | +55% |
| Q1 2026 | $22.3M | +$32.6M |
| Q4 2025 | $46.6M | -17% |
| Q3 2025 | $17M | -3.8% |
| Q2 2025 | $56.6M | +45% |
| Q1 2025 | -$10.3M | +$16.7M |
| Q4 2024 | $56M | +941% |
LFST generated $179M in free cash flow over the past year, up 50% from the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over LFST on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
LFST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +3.9M shares |
| 1 year | +0.6% | +2.3M shares |
| 3 years | +4.7% | +17.6M shares |
LFST has 391M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $24.8M |
| Q2 2026 | $48.5M |
| Q1 2026 | $49.1M |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
LFST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | 1.0x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 2.3x | Moderate |
| Q1 2025 | 5.5x | High |
| Q4 2024 | 14.6x | High |
LFST's net debt is less than a year of its operating earnings (EBITDA), down from 1.6 years a year ago.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
LFST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.6 | Overbought |
| Stochastic | 75.0 | Neutral |
LFST's weekly RSI is 72 (overbought) and its Stochastic is 75 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
LFST PE vs Healthcare Sector
| Metric | LFST | Sector median | Relative |
|---|---|---|---|
| PE | 74x | 26x | 188% above |
| PE % | 3 | 37 | 34 pts below |
LFST is trading at 74x earnings, a 188% premium to the Healthcare sector's median of 26x, though its earnings don't support one.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
LFST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.8 | 11% above |
| 20 week MA | $12.2 | 16% above |
| 50 week MA | $9.22 | 53% above |
| 100 week MA | $7.67 | 84% above |
| 200 week MA | $7.24 | 95% above |
LFST has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
LFST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.0 | $10.1 | -58% |
| 2022 | $10.1 | $4.62 | -54% |
| 2023 | $4.62 | $7.83 | +69% |
| 2024 | $7.83 | $7.49 | -4.3% |
| 2025 | $7.49 | $7.13 | -4.8% |
| 2026 YTD | $7.13 | $14.2 | +98% |
LFST has the edge over HIMS on returns for 2026, with the stronger performance.